Update shared on26 Aug 2025
Fair value Decreased 9.52%The notable reduction in Methode Electronics’ consensus revenue growth forecast, now projecting a steeper annual decline, has driven a lower analyst price target from $10.50 to $9.50.
What's in the News
- Methode Electronics provided fiscal 2026 net sales guidance of $900 million to $1,000 million.
- The company conducted no share repurchases under its buyback program for the most recent period.
- A quarterly dividend of $0.07 per share was declared.
- The company was added to the Russell 3000E Value Benchmark, Russell Microcap Value Benchmark Index, Russell 3000E Value Index, Russell 3000E Index, Russell Microcap Index, and Russell Microcap Value Index.
- The company was dropped from the Russell 2000 Defensive Index and Russell 2000 Value-Defensive Index.
Valuation Changes
Summary of Valuation Changes for Methode Electronics
- The Consensus Analyst Price Target has fallen from $10.50 to $9.50.
- The Consensus Revenue Growth forecasts for Methode Electronics has significantly fallen from -4.7% per annum to -7.0% per annum.
- The Future P/E for Methode Electronics has fallen slightly from 6.36x to 6.07x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.